Literature DB >> 8245278

Experience-dependent neuropsychological recovery and the treatment of alcoholism.

L Roehrich1, M S Goldman.   

Abstract

Accumulating research has shown that some cognitive deficits in recently abstinent alcoholics (e.g., cognitive flexibility, acquisition of novel skills) improve only with remediation in contrast to the spontaneous, time-dependent rebound seen for other tasks. In principle, this facilitated or experience-dependent recovery should enhance acquisition of the content of alcoholism treatment programs, but this relationship has yet to be tested empirically; previous research assessed recovery using only neuropsychological tasks presented by an experimenter. The current investigation focused on treatment-relevant remediation (acquisition of the content of a relapse-prevention [RP] program) using tasks administered by self-guided workbooks. Four groups of male alcoholics received pre- and posttesting. Between the two testing sessions, the groups received neuropsychological remediation tasks (n = 15), ecologically relevant tasks (n = 15), attention-placebo tasks (n = 16), or no intervention (n = 15). Results showed that exposure to both types of remediation produced significant cognitive recovery, with skills transferring to posttest neuropsychological measures and RP acquisition. Hence, cognitive remediation may facilitate alcoholism treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245278     DOI: 10.1037//0022-006x.61.5.812

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  14 in total

1.  Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.

Authors:  Mandy J Bell; Lauren Terhorst; Catherine M Bender
Journal:  J Nurs Meas       Date:  2013

2.  Short-term neuropsychological recovery in clients with substance use disorders.

Authors:  Marsha E Bates; Gerald T Voelbel; Jennifer F Buckman; Erich W Labouvie; Danielle Barry
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

Review 3.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

4.  Cognition, commitment language, and behavioral change among cocaine-dependent patients.

Authors:  Efrat Aharonovich; Paul C Amrhein; Adam Bisaga; Edward V Nunes; Deborah S Hasin
Journal:  Psychol Addict Behav       Date:  2008-12

Review 5.  Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle.

Authors:  Boaz Levy; Roger D Weiss
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

Review 6.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  Adolescent heavy episodic drinking: neurocognitive functioning during early abstinence.

Authors:  Jennifer L Winward; Karen L Hanson; Nicole M Bekman; Susan F Tapert; Sandra A Brown
Journal:  J Int Neuropsychol Soc       Date:  2014-02       Impact factor: 2.892

8.  Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence.

Authors:  Anne Lise Pitel; Hélène Beaunieux; Thomas Witkowski; François Vabret; Bérengère Guillery-Girard; Peggy Quinette; Béatrice Desgranges; Francis Eustache
Journal:  Alcohol Clin Exp Res       Date:  2007-05-20       Impact factor: 3.455

Review 9.  Cognitive rehabilitation of chronic alcohol abusers.

Authors:  D N Allen; G Goldstein; B E Seaton
Journal:  Neuropsychol Rev       Date:  1997-03       Impact factor: 7.444

Review 10.  Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review.

Authors:  Talia Nardo; Jennifer Batchelor; Jamie Berry; Heather Francis; Deyyan Jafar; Thomas Borchard
Journal:  Neuropsychol Rev       Date:  2021-04-19       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.